HLA-dependent tumour development: a role for tumour associate macrophages?

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• Tumor cells utilize Human Leukocyte Antigen (HLA) abnormalities for immune evasion.
• Tumor microenvironment components, including myeloid-derived suppressor cells (MDSC) and M2 tumor-associated macrophages (TAMs), promote tumor growth and suppress anti-tumor immunity.
• The specific role of HLA in these suppressive activities is not well understood.

Purpose of the Study:

• To review the characteristics of MHC class I molecules and their receptors.
• To analyze the crosstalk between tumor cells, TAMs, and immune cells.
• To elucidate the role of HLA in tumor development orchestrated by TAMs.

Main Methods:

• Review of existing literature on MHC class I molecules, their receptors, and immune interactions.
• Analysis of how HLA molecules on tumor cells and TAMs modulate immune cells.
• Examination of regulatory factors affecting MHC class II expression on TAMs.

Main Results:

• Tumor cells and TAMs use HLA class I molecules (HLA-A, B, C, G, E) to down-regulate immune responses by interacting with receptors like LILRB, KIR, and CD94/NKG2A.
• HLA-G and classical MHC-I molecules can promote M2-like TAM polarization and angiogenesis.
• TAMs exhibit epigenetically controlled down-regulation of MHC class II expression via DcR3 and secretion of BAT3, acting as immunosuppressive factors.

Conclusions:

• HLA molecules play a significant role in tumor development, particularly through their interactions orchestrated by TAMs.
• Understanding HLA-TAM crosstalk is crucial for developing novel cancer immunotherapies.
• Targeting HLA-mediated immune suppression could enhance anti-tumor immunity.